Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
hot flashes
Glycididazole
chemoradiotherapy
,
esophageal neoplasms
,
carcinoma
,
squamous cell carcinoma
Taxane
pancreatic neoplasms
,
carcinosarcoma
,
urogenital neoplasms
,
male genital neoplasms
,
neoplasms
,
prostatic neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
malignant pleural effusion
,
sarcoma
,
carcinoma
,
ovarian epithelial carcinoma
,
castration-resistant prostatic neoplasms
,
inflammatory breast neoplasms
,
head and neck neoplasms
,
squamous cell carcinoma
,
synovial sarcoma
,
ureteral neoplasms
,
adolescent development
,
male breast neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma
,
ovarian neoplasms
,
neoplasm metastasis
,
stomach neoplasms
,
peritoneal neoplasms
,
fallopian tube neoplasms
,
recurrence
,
melanoma
,
urologic neoplasms
,
urethral neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
female genital neoplasms
,
pelvic neoplasms
,
unknown primary neoplasms
,
breast neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use